Stock AQST AQUESTIVE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Aquestive Therapeutics, Inc.

Equities

AQST

US03843E1047

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-30 EDT 		5-day change 1st Jan Change
3.36 USD -10.04% Intraday chart for Aquestive Therapeutics, Inc. -21.50% +66.34%
04-29 Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children MT
04-29 Transcript : Aquestive Therapeutics, Inc. - Special Call

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children
MT
Transcript : Aquestive Therapeutics, Inc. - Special Call
Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film
GL
Aquestive Therapeutics, Inc Receives U.S. FDA Approval and Market Access for Libervant? Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm? (epinephrine) Sublingual Film
CI
Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET
GL
Aquestive Therapeutics to Present Crossover Study Data for Libervant Buccal Film at 76th Annual Meeting of the American Academy of Neurology
AQ
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
GL
Aquestive Therapeutics, Inc. to Present Crossover Study Data for Libervant Buccal Film At 76th Annual Meeting of the American Academy of Neurology
CI
Piper Sandler Initiates Aquestive Therapeutics at Overweight With $10 Price Target
MT
Aquestive Therapeutics Files $250 Million Mixed Shelf
MT
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
GL
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
AQ
Aquestive Therapeutics, Inc. Appoints Abigail Jenkins to Board of Directors, Effective April 1, 2024
CI
Raymond James Initiates Aquestive Therapeutics With Outperform Rating, $7 Price Target
MT
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
GL
Top Midday Decliners
MT
Sector Update: Health Care Stocks Steady Premarket Wednesday
MT
Wall Street Set to Open Flat as Investors Look Toward Fed Decision; Oil Prices Drop Sharply
MT
Top Premarket Decliners
MT
Aquestive Therapeutics Prices $75 Million Common Stock Offering; Shares Slump Premarket
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AQST Stock
  4. News Aquestive Therapeutics, Inc.